Alzheimer's disease (AD) is a complex neurodegenerative disease, affecting a significant
part of the population. The majority of AD cases occur in the elderly with a typical age of …

Alzheimer's disease (AD) is a clinically heterogeneous neurodegenerative disease with a
strong genetic component. Several genes have been associated with AD risk for nearly 20 …

Alzheimer's disease (AD) is a progressive neurodegenerative disease that represents a
major cause of death in many countries. AD is characterized by profound memory loss …

Late-onset Alzheimer's disease (AD), the most common neurodegenerative disorder in
western countries, is clinically defined by progressive worsening in cognitive functions along …

In recent years, significant advancements have been made in understanding Alzheimer's
disease from both neurobiological and clinical perspectives. Exploring the complex systems …

Alzheimer's disease (AD) is a disabling neurodegenerative disorder that leads to long-term
functional and cognitive impairment and greatly reduces life expectancy. Early genetic …

As the most common form of dementia, Alzheimer's disease (AD) currently affects nearly 34
million people worldwide, with a prevalence of about 5.4 million cases in the United States …

Alzheimer's disease (AD) is one of the most devastating disorders. Despite the continuing
increase of its incidence among aging populations, no effective cure has been developed …

The search for the genetic factors contributing to Alzheimer disease (AD) has evolved
tremendously throughout the years. It started from the discovery of fully penetrant mutations …

Alzheimer's disease (AD) is the most common form of senile dementia, characterized by the
presymptomatic deposition of β-amyloid plaques followed by neurofibrillary tangles. After …